TTNP

Titan Pharmaceuticals

Delisted

TTNP was delisted on the 1st of October, 2025.

16 hedge funds and large institutions have $1.51M invested in Titan Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
-4
Holders Change %
-20%
% of All Funds
0.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
5
Closed
6
Calls
$257K
Puts
$411K
Net Calls
-$154K
Net Calls Change
+$104K
Name Holding Trade Value Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$531K +$342K +6,576 +181%
Morgan Stanley
2
Morgan Stanley
New York
$413K +$413K +7,939 +793,900%
Citadel Advisors
3
Citadel Advisors
Florida
$179K +$129K +2,481 +257%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$138K +$45.7K +879 +49%
VF
5
Virtu Financial
New York
$87K +$87K +1,665 New
Group One Trading
6
Group One Trading
Illinois
$77K -$114K -2,180 -60%
Bank of New York Mellon
7
Bank of New York Mellon
New York
$40K -$7.27K -140 -15%
ASN
8
Advisory Services Network
Georgia
$23K +$23K +450 New
UBS Group
9
UBS Group
Switzerland
$22K -$40.3K -759 -65%
Bank of America
10
Bank of America
North Carolina
$1K +$500 +7 +100%
APA
11
American Portfolios Advisors
New York
$60
GCP
12
GSA Capital Partners
United Kingdom
-$119K -1,991 Closed
CS
13
Credit Suisse
Switzerland
-$69K -1,160 Closed
Millennium Management
14
Millennium Management
New York
-$50K -844 Closed
Simplex Trading
15
Simplex Trading
Illinois
-$9K -152 Closed